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Background: Danggui (Radix Angelicae Sinensis) is an herb often used in Traditional Chinese medicine. It is used to
promote blood flow and has been used in the treatment of myocardial ischemia-reperfusion injury in animal
models. Angiotensin II (Ang II) has been shown to play important roles in mediating cardiovascular diseases, and
may cause cardiac hypertrophy and apoptosis. This study aimed to investigate whether Danggui has protective
effects on Ang II-induced apoptosis in H9c2 cardiomyoblast cells and study the mechanisms involved.
Methods: We evaluated the effect of Danggui on Ang II-induced apoptosis in an in vitro model. H9c2 cardiomyoblast
cells were cultured in serum-free medium for 4 hr, then treated with Danggui (50, 100 μg/ml) 1 hr pre- or post-Ang II
treatment. After a further 23 hr of culture, cells were harvested for analyses with assays for apoptosis markers and cell
signaling pathways.
Results: Our results showed that Ang II induced upregulation of pro-apoptotic Bad, instability of the mitochondria
membrane potential, cytochrome c release, caspase-9 and caspase-3 activation and cardiomyocyte apoptosis. Pre- or
post-treatment with Danggui reversed all of the above Ang II-induced apoptotic effects in H9c2 cells. Furthermore, the
JNK (SP600125) inhibitor completely blocked Danggui inhibition of caspase-3 activation in Ang II-treated H9c2 cells.
Conclusions: Our results showed that Danggui either pre-treatment or post-treatment highly attenuated the Ang
II-induced apoptosis in cardiomyoblast cells. The findings demonstrated that the anti-apoptosis effect of Danggui is
mediated by JNK and PI3k inhibitors.
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ApoptosisBackground
Cardiovascular disease is a major public health threat for
both men and women in many countries. It remains the
leading cause of death and disability worldwide. Many
factors, such as metabolic syndrome, diabetes mellitus
and hypertension, contribute to cardiovascular disease.
Several clinical studies have reported that metabolic
alterations in diabetes mellitus are associated with mo-
dification of growth hormone (GH) and insulin-like
growth factor-I (IGF-I) synthesis [1] and may play a role* Correspondence: djh@csmu.edu.tw
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unless otherwise stated.in the pathogenesis of heart failure [2]. In addition, IGF-II
and IGF-II receptor (IGF-IIR) have been shown to be asso-
ciated with the development of cardiac hypertrophy [3-6].
Patients with diabetes often show reduced circulating
levels of IGF-I and thus develop IGF-I resistance [7,8].
This situation may induce apoptosis of myocardial cells
and increase the risk of a heart attack. Studies in our
laboratory have shown that the mechanism of apoptosis
is synergistically mediated by angiotensin II- (Ang II)
and the IGF-IR resistance-activated IGF-IIR signaling
pathway [5,9]. This suggests that IGF-IIR and its down-
stream signaling are important in myocardial apoptosis,
and suppression of IGF-IIR signaling pathways can pro-
tect myocardial cells from apoptosis.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Huang et al. BMC Complementary and Alternative Medicine 2014, 14:358 Page 2 of 10
http://www.biomedcentral.com/1472-6882/14/358When the heart receives external stimulation, myocar-
dial cells secrete Ang II [10,11], which may lead to
hypertrophy and apoptosis of the cells [12,13]. Previ-
ously, by using an in vitro myocardial cell culture and an
animal hypertension model (by abdominal aorta ligation
resulting in an elevation in Ang II), we found that Ang
II induces IGF-II and IGF-IIR gene expression that is
mediated by JNK and ERK activation, and sequentially,
IGF-IIR induces Gαq, PKC-α/CaMKIIc and calcineurin
activation [9]. The IGF-II-stimulated myocardial cells
tend towards pathological hypertrophy, as well as the
activation of calcineurin/Bad, resulting in mitochondrial-
dependent apoptosis [5]. Many natural products such as
herbs have been used in the treatment of heart disease.
In this study, we focused on the IGF-IIR-associated
pathway, and investigated whether inhibition of Ang
II-induced cell damage can reduce cardiac apoptosis.
Radix Angelicae Sinensis (Danggui), the dried root of
Angelica Sinensis, is an herb often used in Chinese food
and Traditional Chinese medicine (TCM). Based on early
Chinese medical literature, Danggui can promote blood
flow and has been used to treat disorders with blood de-
ficiency (for review see [14]). It is often used in the treat-
ment of gynecological conditions that possess a blood
deficiency pattern, such as dysmenorrhea and an irregular
menstrual cycle. Danggui has also been reported to have
an immunostimulatory effect in a mitogen-stimulated
lymphocyte proliferation assay in a mouse model in vitro
[15]. In addition, it has been shown to increase nitric oxide
(NO) formation and vascular relaxation in the rat aorta
[16]. It is often tied in with the qi drugs (medicinals for
treating disordered flow of qi, including stagnant flow and
counterflow), used to treat the symptoms of blood stasis.
More than 70 compounds, including alkyl phthalides,
benzenoids, butylphthalide, coumarins, flavones, organic
acids, polysaccharides and trepenes, have been isolated
from roots of Angelica sinensis. Among the identified
main compounds, Z-ligustilide, phthalides and ferulic acid
are known to be its major essential active components
[17,18]. Modern research has also used Danggui extract
for the treatment of myocardial ischemia-reperfusion in-
jury in rats and found that it has a significant protective
effect [19]. Meanwhile, the molecular pathway of Danggui
in myocardial protection is still unclear and further studies
are necessary to clarify the mechanisms underlying the ef-
fects of Danggui. Therefore, we speculated that Danggui
may also have a protective effect against Ang II-induced




Danggui extract powder was provided by Ko Da Pharma-
ceutical (Taoyuan, Taiwan). After the powder was dissolvedin double-distilled water completely, the solution was cen-
trifuged and sterilized by filtering through a 0.2-μm syringe
filter and stored at −80°C.
Cell culture and treatments
H9c2 cardiomyoblasts were obtained from the American
Type Culture Collection (ATCC) and cultured in Dulbecco’s
modified essential medium (DMEM) supplemented with
10% fetal bovine serum, 2 mM glutamine, 100 units/ml
penicillin, 100 μg/ml streptomycin, and 1 mM pyruvate in
humidified air (5% CO2) at 37°C. To investigate the pro-
tective mechanisms of Danggui extract against cardiomyo-
cyte apoptosis, H9c2 cardiomyoblast cells were cultured
in serum-free medium for 4 hr, followed by treatment with
Danggui extract (0, 50, 100, 250, 500 and 1000 μg/ml)
1 hr before or after Ang II treatment, respectively
(Additional file 1: Figure S1). Cell lysate was collected for
analysis 24 hr after Ang II treatment.
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay
In order to test the cytotoxicity of Danggui extract on
H9c2 cardiomyoblast cells, H9c2 cells were treated with
different concentrations of Danggui extract (0, 50, 100,
250, 500, 1000 μg/ml) and the survival rate of H9c2 cells
were measured by MTT assay (M5655, Sigma, St. Louis,
MO, USA) according to the manufacturer’s instructions.
DAPI staining and TUNEL assay
After treatment, H9c2 cells were fixed with 4% paraformal-
dehyde solution for 30 min at room temperature, and
permeabilized with 0.1% Triton X-100 for 2 min. Following
washing with PBS, samples were first incubated with Ter-
minal Deoxynucleotide Transferase-mediated dUTP Nick
End Labeling (TUNEL) (11684817910, Roche, Mannheim,
Germany) reagent containing terminal deoxynucleotidyl
transferase and fluorescent isothiocyanate-dUTP. The cells
were also counterstained with 1 μg/ml DAPI for 30 min.
Samples were analyzed under a fluorescence microscope.
All morphometric measurements were performed using at
least three independent individual samples in a blinded
manner.
JC-1 staining
JC-1 (5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzi-
midazol-carbocyanine iodide) is a lipophilic fluorescent
cation that is incorporated into the mitochondrial mem-
brane, where it can form aggregates due to the state of the
physiological membrane potential of the mitochondria.
This aggregation changes the fluorescence properties of
JC-1, leading to a shift from green to orange fluorescence.
Intact living cells stained with JC-1 therefore exhibit a
pronounced orange fluorescence of mitochondria, which
can be detected by confocal microscopy. Apoptosis results
Figure 1 Danggui extract restores the Ang II-suppressed H9c2
cardiomyoblast cell viability. The cell viability of Ang II-treated H9c2
cells pre-treated (A) and post-treated (B) with Danggui extract was
measured by MTT assay. The results are expressed as the mean ± S.E.M.
of four independent experiments. *P < 0.05, **P < 0.01 represent
significant differences between cells treated with Ang II alone and
cells treated with Ang II and Danggui extract.
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and a subsequent decrease of the orange fluorescence
(and a slight increase of the green fluorescence). By this
means, apoptotic cells can be easily distinguished from
non-apoptotic cells. In brief, after treatment, cells were
washed with PBS and incubated with medium containing
JC-1 staining reagent at 37°C for 20 min followed by
washing with PBS. The mitochondrial membrane poten-
tial was detected by confocal microscopy.
Western blot analysis
Cell lysates were separated by 8–12% gradient SDS-PAGE
and transferred onto nitrocellulose membrane. The mem-
brane was blocked in 5% milk for 1 hr, and blotted with
primary antibody at 4°C overnight. After incubation with
secondary antibody for 2 hr at room temperature, the pro-
tein bands were detected by enhanced chemiluminescence
(ECL, Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Densitometric analysis of immunoblots was performed
using the LAS-3000 imaging system (Fuji Photo Film,
Tokyo, Japan). PI3k antibody (610064) was obtained from
BD Biosciences (San Jose, CA, USA), p-Akt (44–622)
and p-ERK1/2 (44–680) antibodies were obtained from
Biosource Int. (Camarillo, CA, USA), p-Bad antibody
(9296) was obtained from Cell Signaling Technology
(Beverly, MA, USA) and IGF-II antibody (ab63984) was
obtained from Abcam Incorporated (Cambridge, MA,
USA). Other monoclonal antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz).
Inhibitors
H9c2 cells were treated with several inhibitors, including
U0126 (MEK1 and MEK2 inhibitor, #V1121, Promega,
Madison, WI, USA) and SP600125 (JNK inhibitor) (#1496,
TOCRIS /Ellisville, MO, USA).
Statistical analysis
Statistical differences were assessed by one way-ANOVA
using the Duncan test for comparison between groups.
P < 0.05 was considered statistically significant. Data
were expressed as the mean ± SEM.
Results
Effects on the cell viability of cells treated with Ang II
Pre-treatment with Danggui extract at a concentration of
250 μg/ml or higher showed an attenuating effect on Ang
II-induced cell death (Figure 1A), while post-treatment
with Danggui extract also reduced the cell death, but had
a lesser effect than pre-treatment (Figure 1B). We also
analyzed the cytotoxicity of Danggui extract on H9c2 cells,
and found that Danggui extract has no cytotoxic effect on
H9c2 cells at concentrations up to 500 μg/ml, but may
cause obvious cell death at concentrations higher than
500 μg/ml after 24 hr of incubation (data not shown).Based on this result, we used Danggui extract in the range
of 50–500 μg/ml in the following experiments.
Inhibition of Ang II-induced H9c2 cardiomyoblast
apoptosis and DNA fragmentation
The results of DAPI staining showed that Ang II treatment
induced apoptosis in H9c2 cells, while pre-treatment or
post-treatment with Danggui extract (50 to 500 μg/ml) re-
sulted in a significant decrease of Ang II-induced apoptosis
(Figure 2). This result suggested that Danggui extract has
an inhibition effect against Ang II- induced apoptosis in
H9c2 cardiomyoblast cells.
We then used a TUNEL assay to analyze the apoptosis
level in H9c2 cells with a DAPI counterstain to calculate
Figure 2 Danggui extract inhibits the Ang II-induced H9c2 cardiomyoblast cells apoptosis. (A) Influence of pre-treatment or post-treatment
with Danggui extract on Ang II-induced H9c2 cardiomyoblast apoptosis. The blue spot indicates DAPI staining representing the cell number.
Percentage of apoptotic cells following pre-treatment (B) or post-treatment (C) with Danggui extract in the control and Ang II-treated H9c2 cells.
The results are expressed as the mean ± S.E.M. of four independent experiments. #P < 0.05, ###P < 0.001 between the controls and cells treated with
Ang II alone. *P < 0.05, **P < 0.01, ***P < 0.001 between cells treated with Ang II alone and cells treated with Ang II and Danggui extract.
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of apoptotic bodies was increased with Ang II treatment,
and was significantly decreased with pre-treatment or post-
treatment with Danggui extract (at as low as 50 μg/ml)
(Figure 3).
Inhibition of Ang II-induced caspase-9 and caspase-3
activation
To investigate the involvement of caspases in Ang
II-induced cell death, we performed Western blotting ana-
lysis of caspase-9 and caspase-3. As shown in Figure 4, the
protein levels of active caspase-9 and caspase-3 were in-
creased with Ang II treatment, and were significantly de-
creased following both pre-treatment and post-treatment
with Danggui extract in H9c2 cells. This suggests that
Danggui extract can downregulate the mitochondrialdeath pathway to inhibit the apoptosis induced by Ang II.
All the Western data are quantified and the results are
showed in Supplementary data (Additional file 1:
Figure S2).
Rescue effect on the Ang II-induced instability of the
mitochondria membrane potential and cytochrome
c release
In order to validate the involvement of the mitochon-
drial death pathway in H9c2 cells after Ang II treatment,
the mitochondrial membrane potential was assessed by
JC-1 staining. The result demonstrated that Ang II caused
the mitochondria membrane potential to become more
unstable (Figure 5A) and led to cytochrome c release
(Figure 5B). However, when Ang II-treated H9c2 cells
were pre-treated or post-treated with Danggui extract,
Figure 3 Danggui extract inhibits Ang II-induced DNA fragmentation in H9c2 cardiomyoblast cells. (A) Effect of pre-treatment or post-treatment
with Danggui extract on Ang II-induced H9c2 cardiomyoblast apoptosis. The blue spot indicates DAPI counterstaining representing the cell number,
and the green spot represents the apoptotic cells stained by TUNEL assay. Percentage of apoptotic cells following pre-treatment (B) or post-treatment
(C) with Danggui extract in Ang II-induced H9c2 cells. The results are expressed as the mean ± S.E.M. of four independent experiments. #P < 0.05,
###P <0.001 in relation to the control. *P < 0.05 in relation to the H9c2 cells treated with Ang II alone.
Figure 4 Danggui extract inhibits Ang II-induced caspase 9 (A) and caspase 3 (B) activation in H9c2 cardiomyoblast cells. H9c2 cells
were treated with Ang II (5×10−7 M) for 1 hr, and then treated with Danggui extract (50, 100 μg/ml) either 1 hr before (pre-treatment) or 1 hr
after (post-treatment) Ang II treatment, followed by another 23 hr of culture. Cells were harvested and extracted for Western blotting analysis.
α-tubulin was employed as the internal control.
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Figure 5 Danggui extract reverses the Ang II-induced instability of the mitochondria membrane potential and cytochrome c expression.
(A) Ang II induced instability of the mitochondria membrane potential, as detected by Fluorescein isothiocyanate- (FITC-) JC-1 staining in H9c2 cells.
The red image represents that the stable state of Danggui extract could stabilize the mitochondria membrane potential and the green image shows
the cells in an unstable state. (B) H9c2 cells were treated with Ang II (5x10−7 M) for 1 hr, and then treated with Danggui extract (50, 100 μg/ml) either
1 hr before (pre-treatment) or 1 hr after (post-treatment) Ang II treatment, followed by another 23 hr of culture. The protein expression of cytochrome
c was assessed by Western blotting. α-tubulin was employed as the internal control.
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release of the mitochondria membrane protein cyto-
chrome c decreased (Figure 5).
Signaling mechanism of the anti-apoptosis effect in H9c2
cardiomyoblast cells
To understand the mechanism controlling mitochondrial
permeability, we analyzed Bcl-2 family proteins, which are
key regulators and may be involved in the apoptosis of
cardiomyoblast cells. Our results showed that the levels of
anti-apoptotic proteins phosphorylated Bad (p-Bad) and
Bcl-xL were decreased by Ang II treatment, and pre- or
post-treatment with Danggui extract rescued the expres-
sions of Bad (p-Bad) and Bcl-xL (Figure 6A). These results
indicated the anti-apoptotic potential of Danggui extract,
which contributes to stabilizing the mitochondria mem-
brane potential through regulating related proteins against
apoptosis.
In order to elucidate whether Danggui extract inhibits
apoptosis by activating the cardiac IGF-I survival path-
way, phosphatidylinositol 3-kinase (PI3k) and Akt kinase
(Akt) proteins were analyzed by Western blot. It was
found that the phosphorylated PI3k (p-PI3k) and phos-
phorylated Akt (p-Akt) protein levels were greatlydecreased by Ang II, but the protein levels could be re-
covered by both pre-treatment and post-treatment treat-
ment with Danggui extract in H9c2 cells (Figure 6B).
The chemical inhibitors JNK (SP600125) and MEK
(U0126) were applied to investigate the mediator for
Danggui extract-attenuated Ang II-stimulated caspase-3
activation. The results showed that the JNK inhibitor
(SP600125) totally blocked Danggui extract-inhibited
caspase-3 activation in Ang II-treated H9c2 cells, but
the MEK inhibitor (U0126) did not (Figure 6C).
Discussion
Danggui is a key herb in several herbal formulas that are
used to treat several diseases. These Danggui-containing
formulas, such as Danggui Buxue Decoction, have been
shown to have an antioxidant effect [20,21]. Danggui has
also been shown to promote angiogenesis [22]. Danggui
is not only commonly used to treat various gynecological
conditions, but recent studies have also shown that it
can prevent doxorubicin-induced chronic cardiotoxicity
and reduce myocardial injury in animal models [23,24].
A range of active compounds have already been isolated
and identified from Danggui [17]. Among the identified
main compounds, Z-ligustilide, phthalides and ferulic
Figure 6 Danggui extract reversed the Ang II-reduced cardiac survival pathway in H9c2 cardiomyoblast cells. H9c2 cells were treated with
Ang II (5×10−7 M) for 1 hr, and then treated with Danggui extract (50, 100 μg/ml) either 1 hr before (pre-treatment) or 1 hr after (post-treatment) Ang II
treatment, followed by another 23 hr of culture. Western blotting analysis of (A) Bcl-xL and p-Bad expressions, and (B) p-PI3K, PI3K, p-Akt and Akt.
(C) pro-caspase-3 and caspase-3 expression in H9c2 cells treated with inhibitors U0126 (MEK1 and MEK2 inhibitor) and SP600125 (JNK inhibitor).
α-tubulin was used as the internal control.
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nents [17,18].
Ang II has been shown to be a risk factor for cardiovas-
cular diseases, as it has been reported to cause cardiac
hypertrophy and apoptosis. Our previous study demon-
strated that Ang II may evoke IGF-II and IGF-IIR through
the ERK and JNK signaling pathways, and further activates
cardiac cell apoptosis via calcineurin-dependent pathways
[9]. This might be the key step that causes heart failure.
Furthermore, a study performed in our laboratory demon-
strated that pathological hypertrophic stimulus, including
Ang II, up-regulates the IGF-IIR gene expression in H9c2cells, and histone acetylation plays a critical role in
IGF-IIR up-regulation [25]. We also noticed that the Ang
II-induced IGF-IIR gene expression can be reversed by
Danggui treatment (data not shown). Thus, we speculated
that Danggui may prevent the Ang II-induced damage in
cells.
MTTassay showed that Danggui extract has no cytotoxic
effect on H9c2 cells at concentrations up to 500 μg/ml.
Ang II administration caused a significant decrease in the
cell viability (Figure 1), which is in agreement with the
results of another study [26]. Ang II has been shown to
inhibit the IGF-IR signaling pathway and activate the IGF-
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results of the current study showed that Danggui extract
at a concentration between 100 and 500 μg/ml prevents
the H9c2 cell damage caused by Ang II treatment.
It has been shown previously that cell survival is de-
creased in Ang II-treated H9c2 cells [27], and in this
study, we showed that pre-treatment or post-treatment
with Danggui extract significantly protected H9c2 cells
from Ang II-induced apoptosis. Furthermore, the effects
of pre- and post-treatment with Danggui extract on Ang
II-induced H9c2 cells apoptosis were both effective and
dose-dependent (Figure 2B). These results suggested that
Danggui extract has a highly protective effect against
Ang II-induced apoptosis. Ang II stimulation induces
apoptosis of ventricular myocytes in several animal
models [28,29]. The results of a TUNEL assay supported
that apoptotsis induced by Ang II treatment was sig-
nificantly inhibited by both pre-treatment and post-
treatment with Danggui extract.
Ang II activates calcium-calmodulin-dependent protein
phosphatase calcineurin through Galphaq (Gα-q)/PLC
signaling transduction [27,30]. Ca2+/calcineurin also de-
phosphorylates pro-apoptotic Bcl-2 family protein Bad
and induces cytochrome c release from mitochondria to
the cytosol, which further induces caspase activation and
cardiac cell apoptosis [27,31]. We showed that Ang II
stimulation causes apoptosis and induces caspase-9 and
caspase-3 activation (Figure 4). When cells were pre-
treated with Danggui extract, the protein levels of active
caspase-9 and caspase-3 were both significantly decreased
at a concentration of 100 μg/ml. Post-treatment withFigure 7 Schematic diagram. Possible mechanism of Danggui-associated
by Ang II in H9c2 cardiomyoblast cells.Danggui extract still resulted in a significant decrease in
the active caspase-9 level.
Furthermore, it was found that Danggui extract can
block Ang II-induced mitochondria membrane potential
instability and cytochrome c release. In addition, the
effect of pre-treatment with Danggui extract was more
obvious than that of post-treatment. These findings sug-
gest that the protective effect of Danggui extract is me-
diated by stabilization of the mitochondria membrane
potential and inhibition of cytochrome c release against
Ang II-induced caspase-9 and caspase-3 activation and
cell apoptosis. This study reports for the first time that
Danggui extract treatment significantly reduces Ang
II-induced myocyte apoptosis as indicated by the reduc-
tion in caspase-9 and caspase-3 activity.
An earlier study showed that retinoic acid improved
mitochondrial function by inhibiting the mechanical
damage and Ang II-induced reduction in the mitochon-
drial membrane potential, cytochrome c release, and by
increasing the Bcl-2/Bax ratio [32]. In addition, previous
studies have demonstrated that JNK can suppress apop-
tosis in IL-3-dependent hematopoietic cells via phosphor-
ylation of the pro-apoptotic Bcl-2 family protein Bad [33],
and prevents inactivation of the pro-survival Bcl-2 family
protein Bcl-xL by Bad [34]. The results of this study re-
vealed that anti-apoptotic proteins p-Bad and Bcl-xL were
decreased by Ang II treatment, and the levels of p-Bad
and Bcl-xL were significantly increased after pre- or post-
treatment with Danggui extract (Figure 6A). These fin-
dings indicate that the anti-apoptotic potential of Danggui
extract is mediated by stabilizing the mitochondrialinhibition of the mitochondrial-dependent apoptosis pathway induced
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proteins against apoptosis.
Kuo and colleagues [27] reported that IGF-I/IGF-IR via
intracellular signaling pathways involving tyrosine kinase
activity may exert an anti-apoptotic effect via PI3k and
Akt-dependent Bad phosphorylation (p-Bad). Therefore,
the IGF-I/IGF-IR signaling pathway may play an impor-
tant role in the Ang II-reduced cardiac survival pathway
in H9c2 cells. To clarify whether Danggui extract inhi-
bition of apoptosis is mediated by activating this pathway,
the levels of p-PI3k and p-Akt were analyzed. Our results
demonstrated that the Ang II-induced decreased ex-
pressions of these proteins were recovered with both pre-
treatment and post-treatment with Danggui extract. In
addition, angiotensin converting enzyme inhibitor might
increase the IGF-I concentration [35] and Ang II might
decrease circulating IGF-I in rats [36]. Ang II reduces the
IGF-I-stimulated sodium pump activity by attenuating
PI3k/Akt signaling in vascular smooth muscle cells [37].
Therefore, we hypothesized that Ang II may block IGF-I
expression or enhance IGF-I resistance and inhibit the
IGF-IR-mediated PI3k-Akt signaling pathway to induce
H9c2 cell apoptosis, which may recover following treat-
ment with Danggui extract (Figure 7). We also found that
in the cells co-stimulated with Ang II and Danggui,
SP600125 inhibited JNK activity (decreased the pro-
apoptotic response) and activated p-PI3k and p-Akt
(increased the anti-apoptotic effect). However, SP600125
alone or treatment with Ang II and Danggui both in-
creased the active caspase-3 expression (Additional file 1:
Figure S3). The reason for SP600125 (JNK inhibitor) to in-
crease p-Akt activity is still not clear. However, similar
finding has been reported in rat granule neurons [38].
As IGF-II and IGF-IIR also play critical roles in Ang
II-induced apoptosis in H9c2 cells, it is critical to know
which signaling pathways are involved in the Danggui
extract-mediated protective effect. The JNK inhibitor
(SP600125) can block Ang II-induced IGF-IIR expres-
sion and apoptosis [9], suggesting that JNK activation
mediates Ang II-induced apoptosis. However, the results
of the present study also showed that the JNK inhibitor
(SP600125) can completely block the inhibition by
Danggui extract of caspase-3 activation in Ang II-treated
H9c2 cells, but the MEK inhibitor (U0126) does not.
This indicates that JNK activation mediates the protec-
tive effect of Danggui extract. Besides, many previous
studies have shown that JNK activation mediates anti-
apoptotic effects [33,34,39]. Taken together, these findings
and the results of this study suggest that JNK activation
has a dual pro-apoptotic and anti-apoptotic effect on Ang
II- and Danggui extract-mediated cell viability, respec-
tively, although the underlying molecular mechanism re-
mains to be elucidated. Furthermore, to further investigate
the importance of the JNK pathway in Danggui-protectedAng II-induced IGF related cardiac apoptosis, we explored
the role of the IGF-I/IGF-IR pathway in the Danggui
extract-mediated protective effect. By Western blotting
analysis, we examined the IGF II and IGF IIR expressions
and the PI3K/AKT pathway after JNK inhibitor co-
treatment with Danggui and Ang II treatment in H9c2cells
(Additional file 1: Figure S3). Like the JNK inhibitor
(SP600125), the PI3k inhibitor (LY294002) completely
blocked the inhibition by Danggui extract of caspase-3
activation in Ang II-treated H9c2 cells, but the IGF-IR in-
hibitor (AG1024) did not (Additional file 1: Figure S4).
Consequently, according to the inhibitors assay, PI3k acti-
vation mediates the protective effect of Danggui extract.
Conclusions
In conclusion, the induction of downregulation of anti-
apoptotic p-PI3k, p-Akt and Bcl-xL, upregulation of pro-
apoptotic Bad, instability of the mitochondria membrane
potential, cytochrome c release, caspase-9 and caspase-3
activation and cardiomyocyte apoptosis were observed
after Ang II treatment. However, both pre- and post-
treatment with Danggui extract reversed all of the Ang
II-induced effects. We have provided herein the first evi-
dence that Danggui can inhibit AngII-induced apoptosis,
and JNK and PI3k inhibitors can block the anti-apoptosis
effect of Danggui.
Additional file
Additional file 1: Figure S1. Flow diagram of the study. Figure S2.
Quantified Western results of Figures 4, 5, 6 (caspase-9, caspase-3,
cytochrome c, p-PI3k, p-Akt, Bcl-xl and p-Bad). Figure S3. Western
blotting analysis of IGF -I, IGF-IIR, Akt and PI3Kk expressions after JNK
inhibitor co-treatment with Danggui and Ang II in H9c2 cells. Figure S4.
Western blotting analysis of capase-3 after JNK inhibitor co-treatment
with Danggui and Ang II in H9c2 cells.
Competing interests
The authors declare that they have no competing interests. Danggui extract
powder was provided by Ko Da Pharmaceutical. The company had no role
in this study.
Authors’ contributions
CYH, WWK, CHK, FJT and DJH contributed to the experimental design, data
interpretation and editing of the manuscript. DJH and PYL participated in
data acquisition, data analysis and interpretation, and preparation of the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors thank Ko Da Pharmaceutical for providing Danggui extract
powder and batch analysis results of the powder. This study was supported
by the The Taiwan Ministry of Health and Welfare Clinical Trial and Research
Center of Excellence (MOHW103-TDU-B-212-113002) and in part by China
Medical University (CMU-95-176).
Author details
1Graduate Institute of Chinese Medical Science, China Medical University,
Taichung, Taiwan. 2Graduate Institute of Basic Medical Science, China
Medical University, Taichung, Taiwan. 3Department of Health and Nutrition
Biotechnology, Asia University, Taichung, Taiwan. 4Department of Biological
Science and Technology, China Medical University, Taichung, Taiwan.
Huang et al. BMC Complementary and Alternative Medicine 2014, 14:358 Page 10 of 10
http://www.biomedcentral.com/1472-6882/14/3585Department of Sports Sciences, University of Taipei, Taipei, Taiwan. 6School
of Medical Laboratory and Biotechnology, Chung Shan Medical University,
No.110, Sec.1, Jianguo N. Rd., Taichung 40201, Taiwan. 7Clinical Laboratory,
Chung Shan Medical University Hospital, Taichung, Taiwan.
Received: 11 April 2014 Accepted: 19 September 2014
Published: 25 September 2014
References
1. Tannenbaum GS: Growth hormone secretory dynamics in streptozotocin
diabetes: evidence of a role for endogenous circulating somatostatin.
Endocrinology 1981, 108:76–82.
2. Castellano G, Affuso F, Conza PD, Fazio S: The GH/IGF-1 axis and heart
failure. Curr Cardiol Rev 2009, 5:203–215.
3. Chang MH, Kuo WW, Chen RJ, Lu MC, Tsai FJ, Kuo WH, Chen LY, Wu WJ,
Huang CY, Chu CH: IGF-II/mannose 6-phosphate receptor activation
induces metalloproteinase-9 matrix activity and increases plasminogen
activator expression in H9c2 cardiomyoblast cells. J Mol Endocrinol 2008,
41:65–74.
4. Chu CH, Tzang BS, Chen LM, Kuo CH, Cheng YC, Chen LY, Tsai FJ, Tsai CH,
Kuo WW, Huang CY: IGF-II/mannose-6-phosphate receptor signaling
induced cell hypertrophy and atrial natriuretic peptide/BNP expression
via Galphaq interaction and protein kinase C-alpha/CaMKII activation in
H9c2 cardiomyoblast cells. J Endocrinol 2008, 197:381–390.
5. Chu CH, Tzang BS, Chen LM, Liu CJ, Tsai FJ, Tsai CH, Lin JA, Kuo WW, Bau
DT, Yao CH, Huang CY: Activation of insulin-like growth factor II receptor
induces mitochondrial-dependent apoptosis through G(alpha)q and
downstream calcineurin signaling in myocardial cells. Endocrinology 2009,
150:2723–2731.
6. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and
failure. N Engl J Med 1999, 341:1276–1283.
7. Tappy L, Fujita-Yamaguchi Y, LeBon TR, Boden G: Antibodies to insulin-like
growth factor I receptors in diabetes and other disorders. Diabetes 1988,
37:1708–1714.
8. Thrailkill KM: Insulin-like growth factor-I in diabetes mellitus: its physi-
ology, metabolic effects, and potential clinical utility. Diabetes Technol
Ther 2000, 2:69–80.
9. Lee SD, Chu CH, Huang EJ, Lu MC, Liu JY, Liu CJ, Hsu HH, Lin JA, Kuo WW,
Huang CY: Roles of insulin-like growth factor II in cardiomyoblast
apoptosis and in hypertensive rat heart with abdominal aorta ligation.
Am J Physiol Endocrinol Metab 2006, 291:E306–E314.
10. Lijnen P, Petrov V: Renin-angiotensin system, hypertrophy and gene
expression in cardiac myocytes. J Mol Cell Cardiol 1999, 31:949–970.
11. Sernia C: A critical appraisal of the intrinsic pancreatic angiotensin-
generating system. JOP 2001, 2:50–55.
12. Dostal DE, Baker KM: Angiotensin II stimulation of left ventricular
hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J
Hypertens 1992, 5:276–280.
13. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee
RJ, Wexler RR, Saye JA, Smith RD: Angiotensin II receptors and angiotensin
II receptor antagonists. Pharmacol Rev 1993, 45:205–251.
14. Wu YC, Hsieh CL: Pharmacological effects of Radix Angelica Sinensis
(Danggui) on cerebral infarction. Chin Med 2011, 6:32.
15. Wilasrusmee C, Kittur S, Siddiqui J, Bruch D, Wilasrusmee S, Kittur DS: In
vitro immunomodulatory effects of ten commonly used herbs on
murine lymphocytes. J Altern Complement Med 2002, 8:467–475.
16. Rhyu MR, Kim JH, Kim EY: Radix angelica elicits both nitric oxide-dependent
and calcium influx-mediated relaxation in rat aorta. J Cardiovasc Pharmacol
2005, 46:99–104.
17. Chen XP, Li W, Xiao XF, Zhang LL, Liu CX: Phytochemical and
pharmacological studies on Radix Angelica Sinensis. Chin J Nat Med 2013,
11:577–587.
18. Yi L, Liang Y, Wu H, Yuan D: The analysis of Radix Angelicae Sinensis
(Danggui). J Chromatogr A 2009, 1216:1991–2001.
19. Mak DH, Chiu PY, Dong TT, Tsim KW, Ko KM: Dang-Gui Buxue Tang
produces a more potent cardioprotective effect than its component
herb extracts and enhances glutathione status in rat heart mitochondria
and erythrocytes. Phytother Res 2006, 20:561–567.
20. Li YD, Ma YH, Zhao JX, Zhao XK: Protection of ultra-filtration extract from
Danggui Buxue Decoction on oxidative damage in cardiomyocytes of
neonatal rats and its mechanism. Chin J Integr Med 2011, 17:854–859.21. Chiu PY, Leung HY, Siu AH, Poon MK, Dong TT, Tsim KW, Ko KM: Dang-Gui
Buxue Tang protects against oxidant injury by enhancing cellular
glutathione in H9c2 cells: role of glutathione synthesis and regeneration.
Planta Med 2007, 73:134–141.
22. Meng H, Zhu MZ, Guo J, Sun JY, Pei JM, Huang C: [The study on
angiogenesis activity of danggui, chuanxiong and danshen]. Zhong Yao
Cai 2006, 29:574–576.
23. Xin YF, Zhou GL, Shen M, Chen YX, Liu SP, Chen GC, Chen H, You ZQ, Xuan
YX: Angelica sinensis: a novel adjunct to prevent doxorubicin-induced
chronic cardiotoxicity. Basic Clin Pharmacol Toxicol 2007, 101:421–426.
24. Zhang S, He B, Ge J, Li H, Luo X, Zhang H, Li Y, Zhai C, Liu P, Liu X, Fei X:
Extraction, chemical analysis of Angelica sinensis polysaccharides and
antioxidant activity of the polysaccharides in ischemia-reperfusion rats.
Int J Biol Macromol 2010, 47:546–550.
25. Chu CH, Lo JF, Hu WS, Lu RB, Chang MH, Tsai FJ, Tsai CH, Weng YS, Tzang BS,
Huang CY: Histone acetylation is essential for ANG-II-induced IGF-IIR gene
expression in H9c2 cardiomyoblast cells and pathologically hypertensive
rat heart. J Cell Physiol 2012, 227:259–268.
26. Pang JJ, Xu RK, Xu XB, Cao JM, Ni C, Zhu WL, Asotra K, Chen MC, Chen C:
Hexarelin protects rat cardiomyocytes from angiotensin II-induced
apoptosis in vitro. Am J Physiol Heart Circ Physiol 2004, 286:H1063–H1069.
27. Kuo WW, Liu CJ, Chen LM, Wu CH, Chu CH, Liu JY, Lu MC, Lin JA, Lee SD,
Huang CY: Cardiomyoblast apoptosis induced by insulin-like growth
factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced
by angiotensin II. Apoptosis 2006, 11:1075–1089.
28. Chen QM, Tu VC: Apoptosis and heart failure: mechanisms and
therapeutic implications. Am J Cardiovasc Drugs 2002, 2:43–57.
29. Sharov VG, Todor A, Suzuki G, Morita H, Tanhehco EJ, Sabbah HN: Hypoxia,
angiotensin-II, and norepinephrine mediated apoptosis is stimulus
specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and
cyclin D1. Eur J Heart Fail 2003, 5:121–129.
30. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant
SR, Olson EN: A calcineurin-dependent transcriptional pathway for
cardiac hypertrophy. Cell 1998, 93:215–228.
31. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F,
McKeon F, Bobo T, Franke TF, Reed JC: Ca2 + −induced apoptosis through
calcineurin dephosphorylation of BAD. Science 1999, 284:339–343.
32. Choudhary R, Baker KM, Pan J: All-trans retinoic acid prevents angiotensin
II- and mechanical stretch-induced reactive oxygen species generation
and cardiomyocyte apoptosis. J Cell Physiol 2008, 215:172–181.
33. Liu J, Lin A: Role of JNK activation in apoptosis: a double-edged sword.
Cell Res 2005, 15:36–42.
34. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of
death agonist BAD in response to survival factor results in binding to
14-3-3 not BCL-X(L). Cell 1996, 87:619–628.
35. Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J,
Carter C, Di Bari M, Guralnik JM, Pahor M: Relation between use of
angiotensin-converting enzyme inhibitors and muscle strength and
physical function in older women: an observational study. Lancet 2002,
359:926–930.
36. Brink M, Wellen J, Delafontaine P: Angiotensin II causes weight loss and
decreases circulating insulin-like growth factor I in rats through a
pressor-independent mechanism. J Clin Invest 1996, 97:2509–2516.
37. Isenovic ER, Meng Y, Jamali N, Milivojevic N, Sowers JR: Ang II attenuates
IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in
vascular smooth muscle cells. Int J Mol Med 2004, 13:915–922.
38. Yeste-Velasco M, Folch J, Casadesus G, Smith MA, Pallas M, Camins A:
Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against
potassium deprivation-induced apoptosis involves the Akt pathway and
inhibition of cell cycle reentry. Neuroscience 2009, 159:1135–1147.
39. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A: JNK
suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2
family protein BAD. Mol Cell 2004, 13:329–340.
doi:10.1186/1472-6882-14-358
Cite this article as: Huang et al.: Protective effect of Danggui (Radix
Angelicae Sinensis) on angiotensin II-induced apoptosis in H9c2
cardiomyoblast cells. BMC Complementary and Alternative Medicine
2014 14:358.
